Maternal Medications and Human Milk Research Center (M2HMRC)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is set to announce a funding opportunity for the establishment of the Maternal Medications and Human Milk Research Center (M2HMRC) as part of its Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. This initiative aims to advance research on the impact of maternal medications on human milk composition and neonatal health outcomes by addressing knowledge gaps, integrating real-world evidence, developing innovative safety tools, and disseminating findings to a wide audience. The total estimated funding for this cooperative agreement is $2.5 million, with one award anticipated, and applications are expected to be solicited following the publication of the Notice of Funding Opportunity (NOFO) on November 3, 2025. Interested parties can reach out to Dr. Zhaoxia Ren at zren@mail.nih.gov or by phone at 240-463-5046 for further information.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.